NASDAQ : SRTA
Strata Critical Medical, Inc. — Financial statements
Healthcare · Medical Care Facilities · United States
Last price 4.44 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 392.79M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Strata Critical Medical, Inc. (SRTA) reported revenue of 255.97M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 255.97M | 197.14M | 146.82M | 225.18M | 146.12M | 67.16M |
| Cost of Revenue | 201.58M | 156.01M | 117.23M | 183.06M | 123.84M | 54.30M |
| Gross Profit | 54.40M | 41.13M | 29.59M | 42.12M | 22.27M | 12.85M |
| Selling, General & Admin | 53.25M | 51.13M | 49.44M | 82.18M | 67.23M | 42.96M |
| Research & Development | 4.63M | 5.54M | 2.16M | |||
| Amortization of Goodwill & Intangibles | 9.95M | 2.60M | 1.26M | |||
| Operating Expenses | 63.20M | 53.73M | 50.70M | 86.80M | 72.77M | 45.11M |
| Operating Income | -8.81M | -12.61M | -21.11M | -44.68M | -50.50M | -32.26M |
| Interest & Investment Income | 2.57M | 4.24M | 7.21M | 8.44M | 3.43M | 743.00K |
| Other Non Operating Income (Expenses) | 2.98M | 4.28M | -850.00K | 2.12M | 24.23M | -9.15M |
| EBT Excluding Unusual Items | -3.26M | -4.09M | -14.74M | -34.11M | -22.84M | -40.67M |
| Merger & Restructuring Charges | -3.91M | -2.05M | -37.00K | -3.03M | ||
| Gain (Loss) on Sale of Investments | -5.20M | -5.20M | 8.00K | -2.16M | ||
| Asset Writedown | -4.78M | -2.71M | -20.75M | |||
| Legal Settlements | -6.02M | -6.02M | -1.38M | |||
| Other Unusual Items | -2.68M | |||||
| Pretax Income | -23.16M | -20.07M | -16.16M | -57.54M | -28.03M | -40.67M |
| Income Tax Expense | -1.47M | -772.00K | -3.75M | |||
| Earnings From Continuing Operations | -23.16M | -20.07M | -16.16M | -56.08M | -27.26M | -36.92M |
| Earnings From Discontinued Operations | 63.38M | 61.41M | -11.15M | |||
| Net Income | 40.22M | 41.35M | -27.31M | -56.08M | -27.26M | -36.92M |
| Preferred Dividends & Other Adjustments | 17.00K | |||||
| Net Income to Common | 40.22M | 41.35M | -27.31M | -56.08M | -27.26M | -36.94M |
| Shares Outstanding (Basic) | 84.68M | 82.09M | 77.50M | 73.52M | 71.24M | 54.11M |
| Shares Outstanding (Diluted) | 84.68M | 82.09M | 77.50M | 73.52M | 71.24M | 54.11M |
| EPS (Basic) | 0.47 | 0.50 | -0.35 | -0.76 | -0.38 | -0.68 |
| EPS (Diluted) | 0.47 | 0.50 | -0.35 | -0.76 | -0.38 | -0.68 |
| Free Cash Flow | -48.45M | -58.51M | -33.38M | -34.46M | -37.86M | -22.12M |
| Free Cash Flow Per Share | -0.57 | -0.71 | -0.43 | -0.47 | -0.53 | -0.41 |
| Gross Margin | 21.25% | 20.86% | 20.15% | 18.71% | 15.24% | 19.14% |
| Operating Margin | -3.44% | -6.40% | -14.38% | -19.84% | -34.56% | -48.04% |
| Profit Margin | 15.71% | 20.97% | -18.60% | -24.90% | -18.66% | -55.00% |
| Free Cash Flow Margin | -18.93% | -29.68% | -22.74% | -15.30% | -25.91% | -32.93% |
| EBITDA | 7.22M | -5.71M | -17.85M | -37.57M | -44.77M | -31.09M |
| EBITDA Margin | 2.82% | -2.90% | -12.16% | -16.68% | -30.64% | -46.29% |
| D&A For EBITDA | 16.03M | 6.90M | 3.26M | 7.11M | 5.72M | 1.17M |
| EBIT | -8.81M | -12.61M | -21.11M | -44.68M | -50.50M | -32.26M |
| EBIT Margin | -3.44% | -6.40% | -14.38% | -19.84% | -34.56% | -48.04% |
| Advertising Expenses | 4.06M | 4.54M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 16.32M | 30.97M | 16.07M | 27.87M | 41.34M | 2.60M |
| Short-Term Investments | 6.44M | 30.26M | 108.76M | 138.26M | 150.74M | 279.37M |
| Cash & Short-Term Investments | 22.75M | 61.23M | 124.83M | 166.14M | 192.08M | 281.97M |
| Receivables | 43.41M | 39.96M | 19.82M | 21.00M | 10.88M | 5.55M |
| Prepaid Expenses | 7.41M | 7.18M | 4.17M | 17.97M | 12.09M | 6.80M |
| Restricted Cash | 264.00K | 264.00K | 263.00K | 1.15M | 3.08M | 630.00K |
| Other Current Assets | 47.18M | 17.56M | 11.66M | |||
| Total Current Assets | 121.01M | 126.19M | 160.74M | 206.26M | 218.13M | 294.94M |
| Property, Plant & Equipment | 44.64M | 39.55M | 31.30M | 26.38M | 19.73M | 2.76M |
| Long-Term Investments | 200.00K | |||||
| Goodwill | 106.95M | 88.21M | 15.54M | 40.37M | 39.45M | 13.33M |
| Other Intangible Assets | 60.01M | 47.50M | 7.96M | 20.52M | 46.37M | 24.42M |
| Other Long-Term Assets | 90.00K | 24.02M | 41.13M | 1.40M | 1.36M | 232.00K |
| Total Assets | 332.70M | 325.47M | 256.68M | 294.94M | 325.02M | 335.88M |
| Accounts Payable | 18.38M | 19.14M | 9.22M | 23.86M | 16.54M | 6.37M |
| Current Portion of Leases | 1.05M | 652.00K | 682.00K | 4.79M | 3.36M | 438.00K |
| Current Unearned Revenue | 6.84M | 6.71M | 5.98M | |||
| Other Current Liabilities | 26.34M | 12.82M | ||||
| Total Current Liabilities | 45.78M | 19.79M | 22.73M | 35.49M | 26.61M | 12.78M |
| Long-Term Leases | 3.20M | 2.65M | 2.34M | 19.74M | 14.97M | 278.00K |
| Long-Term Deferred Tax Liabilities | 271.00K | 348.00K | 451.00K | 1.88M | 144.00K | |
| Other Long-Term Liabilities | 4.13M | 23.60M | 9.68M | 4.96M | 7.08M | 31.31M |
| Total Liabilities | 53.38M | 46.40M | 34.74M | 60.64M | 50.54M | 44.51M |
| Common Stock | 7.00K | 7.00K | 7.00K | 7.00K | 7.00K | 7.00K |
| Additional Paid-In Capital | 433.22M | 424.62M | 407.08M | 390.08M | 375.87M | 368.68M |
| Retained Earnings | -153.91M | -145.55M | -186.90M | -159.75M | -103.68M | -76.42M |
| Comprehensive Income & Other | 1.75M | 3.96M | 2.29M | -898.00K | ||
| Shareholders' Equity | 279.32M | 279.07M | 221.94M | 234.30M | 274.49M | 291.37M |
| Total Liabilities & Equity | 332.70M | 325.47M | 256.68M | 294.94M | 325.02M | 335.88M |
| Total Debt | 4.25M | 3.31M | 3.02M | 24.52M | 18.33M | 716.00K |
| Net Cash (Debt) | 18.50M | 57.92M | 121.81M | 141.61M | 173.75M | 281.25M |
| Net Cash Per Share | 0.22 | 0.71 | 1.57 | 1.93 | 2.44 | 5.20 |
| Filing Date Shares Outstanding | 88.47M | 86.99M | 79.69M | 75.43M | 72.04M | 70.76M |
| Total Common Shares Outstanding | 88.47M | 86.70M | 79.42M | 75.13M | 71.66M | 70.67M |
| Working Capital | 75.23M | 106.40M | 138.02M | 170.77M | 191.52M | 282.16M |
| Book Value Per Share | 3.16 | 3.22 | 2.79 | 3.12 | 3.83 | 4.12 |
| Tangible Book Value | 112.36M | 143.36M | 198.43M | 173.41M | 188.68M | 253.62M |
| Tangible Book Value Per Share | 1.27 | 1.65 | 2.50 | 2.31 | 2.63 | 3.59 |
| Machinery | 49.53M | 41.90M | 30.30M | 3.04M | 1.47M | 1.11M |
| Leasehold Improvements | 914.00K | 835.00K | 734.00K | 3.02M | 2.80M | 2.51M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 40.22M | 41.35M | -27.31M | -56.08M | -27.26M | -36.92M |
| Depreciation & Amortization | 16.03M | 6.90M | 3.26M | 7.11M | 5.72M | 1.17M |
| Loss (Gain) From Sale of Assets | 344.00K | 68.00K | ||||
| Asset Writedown & Restructuring Costs | 4.78M | 2.71M | 5.76M | 20.75M | ||
| Loss (Gain) From Sale of Investments | 5.20M | 5.20M | 2.16M | |||
| Stock-Based Compensation | 17.01M | 17.83M | 19.89M | 12.50M | 8.28M | 11.28M |
| Provision & Write-off of Bad Debts | 163.00K | |||||
| Other Operating Activities | -55.81M | -58.11M | -3.82M | -10.06M | -26.09M | 5.40M |
| Change in Accounts Receivable | -5.77M | -12.03M | -998.00K | -10.25M | -5.35M | -1.74M |
| Change in Accounts Payable | -1.18M | 2.38M | -8.34M | 9.05M | 9.90M | 2.52M |
| Change in Unearned Revenue | -623.00K | 1.68M | -119.00K | 117.00K | 737.00K | 1.56M |
| Change in Other Net Operating Assets | 527.00K | -1.11M | 6.45M | -5.65M | -5.31M | -4.90M |
| Operating Cash Flow | -36.03M | -48.91M | -2.52M | -32.35M | -37.13M | -21.63M |
| Capital Expenditures | -12.41M | -9.60M | -30.86M | -2.11M | -730.00K | -488.00K |
| Sale of Property, Plant & Equipment | 138.00K | |||||
| Cash Acquisitions | -101.36M | -66.53M | -2.23M | -48.10M | -23.07M | |
| Divestitures | -3.10M | -2.81M | ||||
| Sale (Purchase) of Intangibles | -1.07M | -1.42M | -2.12M | -12.36M | ||
| Investment in Securities | 119.45M | 150.10M | 34.20M | 19.06M | 128.17M | -280.26M |
| Investing Cash Flow | 1.51M | 69.75M | -1.02M | 17.09M | 79.34M | -316.17M |
| Total Debt Repaid | -1.17M | |||||
| Net Debt Issued (Repaid) | -1.17M | |||||
| Issuance of Common Stock | 174.00K | 193.00K | 168.00K | 70.00K | 87.00K | 335.04M |
| Repurchase of Common Stock | -8.44M | -9.11M | -5.93M | -146.00K | -1.17M | -3.17M |
| Financing Cash Flow | -8.60M | -8.91M | -5.76M | -76.00K | -1.08M | 330.70M |
| Foreign Exchange Rate Adjustments | -616.00K | -339.00K | -80.00K | -66.00K | 72.00K | -9.00K |
| Net Cash Flow | -43.74M | 11.59M | -9.37M | -15.40M | 41.20M | -7.11M |
| Free Cash Flow | -48.45M | -58.51M | -33.38M | -34.46M | -37.86M | -22.12M |
| Free Cash Flow Margin | -18.93% | -29.68% | -22.74% | -15.30% | -25.91% | -32.93% |
| Free Cash Flow Per Share | -0.57 | -0.71 | -0.43 | -0.47 | -0.53 | -0.41 |
| Levered Free Cash Flow | -20.09M | -26.98M | -28.89M | -11.67M | -18.34M | |
| Unlevered Free Cash Flow | -20.09M | -26.98M | -28.89M | -11.67M | -18.34M | |
| Cash Income Tax Paid | 157.00K | 87.00K | 16.00K | |||
| Change in Working Capital | -7.05M | -9.08M | -3.01M | -6.74M | -17.00K | -2.56M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 392.79M | 415.42M | 332.83M | 263.46M | 256.52M | 622.98M |
| Enterprise Value | 374.29M | 342.98M | 220.24M | 114.58M | 71.44M | 319.51M |
| Last Close Price | 4.44 | 4.81 | 4.25 | 3.53 | 3.58 | 8.83 |
| PE Ratio | 9.41 | 10.05 | ||||
| Forward PE | 104.47 | 186.22 | ||||
| PS Ratio | 1.53 | 2.11 | 2.27 | 1.17 | 1.76 | 9.28 |
| PB Ratio | 1.41 | 1.49 | 1.50 | 1.12 | 0.94 | 2.14 |
| P/TBV Ratio | 3.50 | 2.90 | 1.68 | 1.52 | 1.36 | 2.46 |
| EV/Sales Ratio | 1.46 | 1.74 | 1.50 | 0.51 | 0.49 | 4.76 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.10 | 0.07 | 0.00 |
| Net Debt / Equity Ratio | -0.07 | -0.21 | -0.55 | -0.60 | -0.63 | -0.96 |
| Net Debt / EBITDA Ratio | -2.56 | 10.15 | 6.83 | 3.77 | 3.88 | 9.05 |
| Net Debt / FCF Ratio | 0.38 | 0.99 | 3.65 | 4.11 | 4.59 | 12.72 |
| Asset Turnover | 0.87 | 0.68 | 0.53 | 0.73 | 0.44 | |
| Quick Ratio | 1.45 | 5.11 | 6.37 | 5.27 | 7.63 | 22.49 |
| Current Ratio | 2.64 | 6.38 | 7.07 | 5.81 | 8.20 | 23.07 |
| Return on Equity (ROE) | -9.22% | -8.01% | -7.08% | -22.04% | -9.63% | |
| Return on Assets (ROA) | -1.86% | -2.71% | -4.78% | -9.01% | -9.55% | |
| Return on Capital Employed (ROCE) | -3.10% | -4.10% | -9.00% | -17.20% | -16.90% | -10.00% |
| Earnings Yield | 10.62% | 9.95% | -8.20% | -21.29% | -10.63% | -5.93% |
| FCF Yield | -12.33% | -14.08% | -10.03% | -13.08% | -14.76% | -3.55% |
| Buyback Yield / Dilution | -6.59% | -5.93% | -5.41% | -3.21% | -31.65% | -26.18% |